China National Accord Medicines Corporation Ltd. (SHE:000028)

China · Delayed Price · Currency is CNY

25.83

+0.08 (0.31%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Retail	22.36B	-	24.11B	22.48B	19.44B
Retail Growth	-	-	7.25%	15.64%	44.04%
Sub-Underwriter	52.98B	-	50.20B	46.83B	41.07B
Sub-Underwriter Growth	-	-	7.19%	14.03%	2.64%
Headquarters	7.41M	-	5.38M	7.95M	9.49M
Headquarters Growth	-	-	-32.35%	-16.21%	-1.84%
Offset of Business Segment	-969.77M	-	-867.28M	-960.33M	-867.46M
Total	74.38B	-	73.44B	68.36B	59.65B
Total Growth	-	-	7.44%	14.60%	13.00%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	74.38B	75.48B	73.44B	68.36B	59.65B
China Growth	-1.46%	2.77%	7.44%	14.60%	13.00%
Total	74.38B	75.48B	73.44B	68.36B	59.65B
Total Growth	-1.46%	2.77%	7.44%	14.60%	13.00%

Source: S&P Global Market Intelligence.